Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA-Reference-Cited by-同舟云学术

Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA

Published:2024-05-13 Issue:8 Volume:103 Page:2699-2709
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Tang Zhexuan,Zhu Desheng,Li Xun,Yan Haipeng,Luo Ting,Xie Longlong,Yang Yufan,Tang Minghui,Jiang Xuedan,Huang Jiaotian,Zhang Xinping,Zhou Lifang,Lei Yefei,Xiao Zhenghui,Lu Xiulan^ORCID

Funder

Department of Science and Technology of Hunan Province

Hunan Provincial Key Laboratory of emergency medicine for children

National Natural Science Foundation of China

Health Commission of Hunan Province

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05780-2.pdf

Reference32 articles.

1. Griffin G, Shenoi S, Hughes GC (2020) Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 34(4):101515

2. Al-Samkari H, Berliner N (2018) Hemophagocytic lymphohistiocytosis. Annu Rev Pathol 13:27–49

3. Bergsten E, Horne A, Arico M, Astigarraga I, Egeler RM, Filipovich AH et al (2017) Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood 130(25):2728–2738

4. Canna SW, Marsh RA (2020) Pediatric hemophagocytic lymphohistiocytosis. Blood 135(16):1332–1343

5. Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A et al (2019) Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer 66(11):e27929